- Mar 5

Dr. Bo Rode Hansen explains why he joined LIfT as a Non-Executive Director

We recently caught up with Dr. Bo Rode Hansen, a Non-Executive Director at LIfT, to find out what motivated him to join LIfT and why he thinks our platform could make a real difference for patients with cancer.

Recent Posts

See All

LIfT demonstrates how IMANs rapidly infiltrate tumours and recruit in other immune cells to destroy solid tumours together

LIfT’s CEO challenges out dated thinking that therapies focused on T-Cells alone are enough to achieve complete remission in most solid tumours

LIfT BioSciences appoints Dr Bo Rode Hansen and Dr Marco Gottardis to its Board of Directors

Dr. Bo Rode Hansen explains why he joined LIfT as a Non-Executive Director

Recent Posts

Stay up-to-date with our progress and latest news

Company

Quick Links